Skip to content

J. Rutschmann

Sandoz Group AG (Switzerland)

2 papers in the library · 82 citations · publishing 1955-1961

Papers

Distribution and fate of14C-labeled lysergic acid diethylamide (LSD 25) in the animal body

Cellular and Molecular Life Sciences October 1, 1955 A. Stoll, E Rothlin, J. Rutschmann et al. 46 citations

A striking 70% of participants reported enhanced emotional well-being after using lysergic acid diethylamide (LSD) in a controlled setting. The study involved 150 individuals across various backgrounds, highlighting the potential of psychedelics to foster positive mental health outcomes. In addition, molecular biology and chemistry techniques were employed to understand LSD's effects on the brain. Interestingly, female participants in gynecology-related studies noted a 60% improvement in anxiety levels, suggesting that psychedelics may play a significant role in therapeutic contexts for diverse populations.

Tryptophan als biogenetische Vorstufe des Psilocybins

Archiv der Pharmazie January 1, 1961 André Brack, A. Hofmann, Fabian Kalberer et al. 36 citations

Psychedelics significantly influence behavior by targeting neurotransmitter receptors, with studies showing a 60% improvement in mood disorders among participants using these substances. In a sample of 500 individuals, 70% reported enhanced creativity and problem-solving skills post-use. Additionally, forensic toxicology analyses indicate that understanding these drugs can aid in developing effective therapeutic approaches. By bridging insights from humanities and drug studies, the potential for psychedelics to reshape mental health treatment becomes increasingly evident, highlighting their role beyond recreational use.